CAPR NASDAQ Week ended 24 Jul 2026

Weekly Investor Report

Capricor Therapeutics Inc · Healthcare · Biotechnology

Open interactive chart View report data Download investor PDF
Latest close 19.70 USD
1.3% latest week
Weekly setup

Weak trend

The weekly trend is not active. Price is -27.5% below the Trend Line and sits at 42.7% of its 52-week range. The latest completed week returned 1.3%, after a -25.5% four-week move. The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive. Options positioning is volatility with 59/100 conviction, while the latest news-sentiment score is 49/100. Near-term considerations: earnings are due in 11d.

Setup score 30 out of 100
Latest Close 19.70 USD 24 Jul 2026
1W Return 1.3% latest completed week
4W Return -25.5% short-term follow-through
12W Return -36.3% quarterly tape
Trend Breadth 53.8% 28 of 52 weeks active
Volume Ratio 1.6x vs 13-week average
What is working
  • Price is above Fair Value, showing premium demand versus the model.
  • Volume is elevated versus the 13-week average, confirming attention.
What could go wrong
  • The trend backdrop is inactive, so price action has not confirmed a constructive regime.
  • Price is below the Trend Line, which keeps downside pressure in focus.
  • Activity pressure is negative, which weakens the current setup.
  • Activity pressure is weak, so confirmation is not yet broad enough.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 1.3% Latest completed week; four-week move -25.5%. Indicator stack 30/30 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 59/100 conviction; expected move 74.5%. News sentiment 49/100 64 relevant articles in the latest sentiment read. Event risk 11d Next report is scheduled for 10 Aug 2026; event risk rises as the date approaches.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is not active. Price is -27.5% below the Trend Line and sits at 42.7% of its 52-week range. The latest completed week returned 1.3%, after a -25.5% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
30 Jan 6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.3312-week average 0.61

12-week confirmation

Trend active7/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure2/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership9/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.33Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers

No recent accumulation markers. 1 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is -25.5% over four weeks, -36.3% over 12 weeks, and 179.0% over one year. The current trend has remained active for 0 consecutive weeks.

Performance by holding period

1W1.3%
4W-25.5%
12W-36.3%
26W-15.1%
52W179.0%
Active trend streak0 weeks
Active weeks in one year28
Trend breadth53.8%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-1.10Latest activity-pressure read.
Pressure change-2.7%Four-week change in activity pressure.
Leadership-8.82Latest relative-leadership reading.
RS change-138.1%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality is middle-of-the-pack; growth is moderate; valuation is neither clearly cheap nor expensive.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Dec 2025 Field coverage 67% Model confidence 64%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength69/100Blend of value, momentum, and quality. Underlying universe rank 32; rank 1 is best.
Value59/100Relative valuation strength. Underlying universe rank 42; rank 1 is best.
Quality57/100Profitability and accounting quality. Underlying universe rank 44; rank 1 is best.
Momentum59/100Medium-term price momentum. Underlying universe rank 42; rank 1 is best.
Growth59/100Revenue and earnings growth. Underlying universe rank 42; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
-
Price divided by trailing earnings.
Price / sales
-
Market value relative to trailing revenue.
EV / EBITDA
1.2x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
-6.7%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
-
Gross profit retained from each unit of revenue.
Operating margin
-
Operating profit retained from revenue.
Free-cash-flow margin
-
Free cash flow generated from revenue.
Return on invested capital
-43.0%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-
Latest one-year revenue growth.
EPS growth
-
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-
Latest one-year free-cash-flow growth.
Piotroski F-score
2/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
-
Cash dividends relative to market value.
Buyback yield
-20.8%
Net share repurchases relative to market value.
Shareholder yield
-20.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.1x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

CAPR shows volatility options pressure with a 59/100 conviction score, put-call volume ratio of 0.08, expected move of 74.5%, and Sharemaestro trend signal inactive.

Conviction59/100
Expected move74.5%
Put/call volume0.08
Pressure92
Speculation49
Volatility96
Trend agreement0
Open options detail
Insider activity8 / 12

8 acquisitions and 12 disposals in the latest 180-day insider tape.

Acquisitions / disposals over the latest 180 days. Insider activity is context, not a stand-alone signal.
News sentiment49/100

Weighted news tone is neutral across 64 relevant articles.

17 positive · 33 neutral · 14 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings11dNext report is scheduled for 10 Aug 2026; event risk rises as the date approaches.
Options expected move74.5%Nearest-chain priced movement where available.
52-week drawdown-51.2%Distance below the 52-week high.
13-week volatility6.5%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher10 of 2616 weeks finished lower.
Best week+27.0%Week of 20 Feb.
Worst week-12.4%Week of 1 May.
Latest week+1.3%Week of 24 Jul.

Shape of recent returns

Strong gains6
Modest gains4
Flat weeks0
Modest losses6
Sharp losses10
Recent vol6.5%13-week weekly-return volatility.
Base vol56.1%52-week weekly-return volatility.
Up/down split22/30Count of positive and negative weeks in the 52-week window.
Average skew25.6% / -6.7%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape34/100

Trend, activity pressure, participation, and risk combine to a 34/100 tape read.

 Indicator analysis45/100

Latest 12-week confirmation: trend 7/12, activity pressure 2/12, relative leadership 9/12.

Activity pressure 0.33; 1 reversal markers Factors60/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Buyback Yield rank 91; Small Cap Core rank 49 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options37/100

CAPR shows volatility options pressure with a 59/100 conviction score, put-call volume ratio of 0.08, expected move of 74.5%, and Sharemaestro trend signal inactive.

Volatility · Volatility expansion watch · Expected move 74.5% Sentiment49/100

Weighted news tone is neutral across 64 relevant articles.

Capricor Therapeutics Shares Fall After B. Riley, Roth Capital Downgrades Insiders8 / 12

8 acquisitions and 12 disposals in the latest 180-day insider tape.

 Earnings11d

Next report is scheduled for 10 Aug 2026; event risk rises as the date approaches.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
24 Jul 202619.70 USD1.3%27.17 USD12.33 USD-1.10-8.8210.2MOff
17 Jul 202619.44 USD-9.6%27.50 USD12.23 USD-1.03-10.576.4MOff
10 Jul 202621.51 USD-7.3%27.78 USD12.13 USD-0.94-4.247.4MOff
3 Jul 202623.21 USD-12.2%27.93 USD12.02 USD-0.986.248.6MOff
26 Jun 202626.44 USD-6.8%28.05 USD11.90 USD-1.0723.169.9MOff
19 Jun 202628.38 USD10.0%27.35 USD11.76 USD-1.1227.626.2MOn
12 Jun 202625.80 USD-3.4%26.59 USD11.61 USD-1.0720.875.1MOn
5 Jun 202626.71 USD-10.8%25.92 USD11.48 USD-0.8929.143.4MOn
29 May 202629.96 USD3.8%25.23 USD11.34 USD-0.5339.332.5MOn
22 May 202628.87 USD0.3%24.45 USD11.17 USD-0.2440.134.6MOn
15 May 202628.79 USD-5.2%23.69 USD11.02 USD0.1043.366.3MOn
8 May 202630.38 USD-1.7%22.94 USD10.86 USD0.4153.126.8MOn
1 May 202630.91 USD-12.4%22.16 USD10.69 USD0.4367.805.1MOn
24 Apr 202635.27 USD1.6%21.38 USD10.52 USD0.4197.414.2MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.